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Investment in malaria elimination: a leap of faith in need 
of direction
The decrease in malaria burden in the past decade has 
coincided with a greater than 15-times increase in 
international spending on malaria control1 and a shift 
in approach towards a goal of local elimination in many 
endemic countries. Although investment growth rates 
have slowed, the decrease in malaria transmission is 
expected to continue, with some indications that these 
gains are more resilient than expected.2
In The Lancet Global Health, Ubydul Haque and 
colleagues3 assess the performance of the Bangladesh 
National Malaria Control Program (NMCP) in delivering 
malaria control activities in the country’s remaining 
endemic areas after 5 years of investment from the 
Global Fund to Fight AIDS, Tuberculosis and Malaria. 
The analysis has several strengths and weaknesses that 
are informative for economic assessments of malaria 
control programmes in countries moving towards 
elimination.
From an economic perspective there are three points 
of relevance to investment in malaria elimination. First 
is that of allocative eﬃ  ciency—whether this is the best 
use of scarce resources. Second is the identiﬁ cation of the 
most eﬃ  cient conﬁ guration of interventions to meet the 
aim of elimination, and third is the technical eﬃ  ciency 
in implementation of these interventions. Haque and 
colleagues focus mainly on the third question, with 
some extension to the eﬀ ectiveness of interventions in 
reducing transmission.
With regard to allocative eﬃ  ciency, although malaria 
elimination is a laudable cause, the intuitive economic 
case for it is not well substantiated compared with 
support for continuing control;4,5 as the burden 
of malaria continues to decrease, the argument 
for elimination will also become progressively less 
compelling compared with investment in other causes 
of illness. The economic case is further complicated by 
diﬃ  culties in quantiﬁ cation of the probability of success 
and the eﬀ ect of factors that aﬀ ect the likelihood of 
success, notably the spread of artemisinin resistance or 
a resurgence of malaria, which are aﬀ ected by uncertain 
factors such as future land use, climatic changes, and 
economic development. Despite these uncertainties, the 
political will and donor support for elimination are well 
established, so economic assessments are best focused 
on how to direct resources towards this aim.
Estimation of the eﬀ ectiveness of malaria control in 
achieving elimination is challenging. Eﬀ ective control 
has reduced malaria in regions of low transmission, 
but other processes have also contributed, including 
deforestation, urbanisation, rising incomes, and 
improved access to health care.2,6 Haque and colleagues 
draw attention to the association between insecticide-
treated net (ITN) coverage and decreasing prevalence 
of malaria (prevalence rate ratio for any malaria with 
>0·50 ITN per person 0·79 [95% CI 0·77–0·81]), and an 
even larger decrease in mortality (0·24 [0·09–0·65]). 
Was this association causal or coincidental? Improved 
ITN coverage is indicative of greater support for all 
aspects of malaria control, notably early diagnosis and 
eﬀ ective treatment. Furthermore, the disproportionate 
reduction in mortality compared with malaria cases 
identiﬁ ed by Haque and colleagues suggests that 
provision of artemisinin combination treatments might 
well have been a major contributor to the decreased 
mortality, and could also have reduced transmission.7,8 
In one of the largest ever studies of ITN eﬃ  cacy, 9 done 
in Rakhine State, Myanmar (adjacent to the study area 
of Haque and colleagues), ITNs were shown to have little 
antimalarial eﬃ  cacy largely because of the early biting 
exophilic behaviour of the main malaria vectors. 
An understanding of the extent to which malaria control 
as a whole or any speciﬁ c intervention contributes to 
lowering of transmission cannot be derived reliably from 
historical associations between intervention coverage and 
decreasing transmission. Assessments of malaria control 
programmes might therefore be best focused on their 
technical eﬃ  ciency in delivery of predeﬁ ned objectives 
based on robust study designs.
Haque and colleagues provide a positive example of 
how an assessment of technical eﬃ  ciency should be 
done. Costs of malaria control activities were estimated 
using donor and NMCP budgets (their ﬁ nancial costs), a 
practice that is often deemed less adequate than using 
the societal opportunity cost. Although economic 
costs are needed to estimate the allocative eﬃ  ciency 
of interventions, in this context ﬁ nancial costs provide 
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donors with the information most relevant to their 
perspective. Combination of ﬁ nancial costs with 
programmatic outputs, such as ITN coverage and health 
education per person per year, enables donors to gauge 
and compare how eﬃ  ciently their funding is being 
used in diﬀ erent countries. Use of other downstream 
outcomes including the cost per case treated or 
extension to measures such as disability-adjusted 
life-years (DALYs) or deaths averted is not warranted 
because as malaria transmission and incidence fall, the 
relative cost per case treated (or DALY averted) will rise 
exponentially, penalising eﬀ ective programmes.
Donor funding for malaria elimination has increased 
substantially out of a belief that this investment is worthy. 
The most pressing and challenging need is to identify 
optimum conﬁ gurations of interventions to achieve 
elimination. Well designed intervention studies can oﬀ er 
some such guidance but these are mostly limited to one 
intervention and setting. Economic–epidemiological 
models can simulate the eﬀ ect of conﬁ gurations of 
interventions to achieve elimination as quickly as possible, 
subject to budget constraints. National malaria control 
programmes are best assessed on their technical eﬃ  ciency 
in delivering these objectives, and need not rely on 
uncertain associations between their activities and health 
outcomes, or their allocative eﬃ  ciency as compared with 
alternative uses of these resources.
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